Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review - Page 2 of 82
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Lilly receives US FDA approval for Retevmo

Retevmo was approved under the FDA’s Accelerated Approval regulations based on the LIBRETTO-001 Phase 1/2 trial’s endpoints of objective response rate (ORR) and duration of response (DoR). Continued